Logo
  • Search
  • Subscribe
  • Login
  • News
  • Business
  • Opinion
  • Archive
  • Jobs Market
  • About DT
  • Contact
  • Search
  • Subscribe
  • Login

Pneumonia vaccine remains expensive after 10 years of Gavi’s AMC funding

News February 16, 2018

When the innovative USD 1.5 billion financing mechanism, the AMC, was launched by Gavi ten years ago, it was expected to do two things: accelerate the distribution of pneumonia vaccine among children in poor countries and incentivise more suppliers to enter the market, thereby increasing competition and pushing prices down. The AMC succeeded on the first but failed on the second.

baby vaccine Photo Rumi Consultancy World Bank.jpg

If you are new to Development Today and would like to continue reading this article, send us a mail at subscribers@devtoday.no, including your name, title, organisation, and email contact, and you will receive a free Guest Pass, along with weekly updates.

Log in or subscribe

Tags:

AMC vaccine deal Global health
  • Home
  • Archive
  • 2018
  • DT 2 / 2018
  • Pneumonia vaccine remains expensive after 10 years of Gavi’s AMC funding

Development Today AS
Box 140
1371 Asker
Norway
Tel: +47 66902660
E-mail: devtoday@devtoday.no

  • News
  • Business
  • Opinion
  • Archive
  • About DT
  • Privacy and Cookie policy
  • Contact
  • Log in
  • Subscribe

Design and development: Snapper Net Solutions